Sumitomo Pharma Management
Management criteria checks 2/4
Sumitomo Pharma's CEO is Hiroshi Nomura, appointed in Apr 2018, has a tenure of 11.83 years. directly owns 0.018% of the company’s shares, worth €172.34K. The average tenure of the management team and the board of directors is 3 years and 5.3 years respectively.
Key information
Hiroshi Nomura
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -JP¥174b |
| Sep 30 2023 | n/a | n/a | -JP¥135b |
| Jun 30 2023 | n/a | n/a | -JP¥144b |
| Mar 31 2023 | n/a | n/a | -JP¥75b |
| Dec 31 2022 | n/a | n/a | -JP¥8b |
| Sep 30 2022 | n/a | n/a | JP¥13b |
| Jun 30 2022 | n/a | n/a | JP¥83b |
| Mar 31 2022 | n/a | n/a | JP¥56b |
| Dec 31 2021 | n/a | n/a | JP¥32b |
| Sep 30 2021 | n/a | n/a | JP¥55b |
| Jun 30 2021 | n/a | n/a | JP¥43b |
| Mar 31 2021 | JP¥101m | JP¥83m | JP¥56b |
Compensation vs Market: Insufficient data to establish whether Hiroshi's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Insufficient data to compare Hiroshi's compensation with company performance.
CEO
Hiroshi Nomura (66 yo)
6yrs
Tenure
JP¥101,000,000
Compensation
Mr. Hiroshi Nomura served as Director of Roivant Sciences Ltd. since September 16, 2022 until August 31, 2023. He has been Chief Executive Officer and President of Sumitomo Pharma Co., Ltd.(Formerly Sumit...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 6yrs | JP¥101.00m | 0.018% ¥ 172.3k | |
| Sr. Mngg Exec. Off. of Glo. Crprate Stgy | 8.3yrs | no data | 0.013% ¥ 126.2k | |
| Mngg Exec. Officer of Global Data Design | 7yrs | no data | 0.0015% ¥ 14.6k | |
| Executive Officer of Corporate Governance & Communications | 2yrs | no data | no data | |
| M.E.O. of Sales & Marketing Div. | 2yrs | no data | no data | |
| Managing Executive Officer of External Affairs | no data | no data | no data | |
| Managing Executive Officer of Drug Research Division | 3.8yrs | no data | 0.0038% ¥ 36.5k | |
| E.O. of R. Aff. | 1.3yrs | no data | no data | |
| Managing Executive Officer of Business Development & Management and Director | 7yrs | no data | 0.0020% ¥ 19.4k | |
| Executive Officer | 1.3yrs | no data | no data | |
| Executive Officer | 1.3yrs | no data | no data | |
| Managing Exe. Officer of Tech. R&D Div. | 3yrs | no data | no data |
3.0yrs
Average Tenure
64yo
Average Age
Experienced Management: DPM's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 11.8yrs | JP¥101.00m | 0.018% ¥ 172.3k | |
| Sr. Mngg Exec. Off. of Glo. Crprate Stgy | 7.8yrs | no data | 0.013% ¥ 126.2k | |
| Mngg Exec. Officer of Global Data Design | 1.8yrs | no data | 0.0015% ¥ 14.6k | |
| Managing Executive Officer of Drug Research Division | 3.8yrs | no data | 0.0038% ¥ 36.5k | |
| Managing Executive Officer of Business Development & Management and Director | 10yrs | no data | 0.0020% ¥ 19.4k | |
| Independent Outside Director | 5.8yrs | no data | no data | |
| Independent Outside Director | 2.8yrs | no data | no data | |
| Independent Outside Director | 4.8yrs | no data | no data | |
| Full-Time Audit & Supervisory Board Member | 5.8yrs | no data | 0.0053% ¥ 51.0k | |
| Outside Audit & Supervisory Board Member | 5.8yrs | no data | no data | |
| Full-Time Audit & Supervisory Board Member | less than a year | no data | 0.0020% ¥ 19.4k | |
| Independent Outside Director | 1.8yrs | no data | no data |
5.3yrs
Average Tenure
65yo
Average Age
Experienced Board: DPM's board of directors are considered experienced (5.3 years average tenure).